Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00677378 · ClinicalTrials.gov registry record

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

A clinical trial, sponsored by Medical College of Wisconsin.

Completed
Registry status
77
Enrollment target

NCT00677378: Completed study, sponsored by Medical College of Wisconsin.

NCT00677378 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00677378 has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
77 participants
Enrollment target

Study Summary

We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2006-12
Est. Completion 2015-10
Medical College of Wisconsin

447 total trials

What the finished NCT00677378 record still lists

NCT00677378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00677378 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00677378 about?

NCT00677378 is a clinical study titled "Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain". We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

What is the current status of trial NCT00677378?

This trial is currently completed. The enrollment target is 77 participants. The study started on 2006-12. Estimated completion is 2015-10.

Who is sponsoring clinical trial NCT00677378?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00677378, the US trial registry maintained by the National Library of Medicine. NCT00677378 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.